Related content

Striatal dopamine D₂ receptor density in neuroleptic-naive and in neuroleptic-free schizophrenic patients: an ¹²³I-IBZM-SPECT study

By Lomeña Francisco   Catafau Ana   Parellada Eduard   Bernardo Miquel   Font Mireia   Gutiérrez Fernando   Pavía Javier  

Psychopharmacology, Vol. 172, Iss. 2, 2004-03 ,pp. : 165-169

Springer Publishing Company

Access to resources Recommend Favorite

Preliminary evidence of striatal D2 receptor density as a possible biological marker of prognosis in naive schizophrenic patients

By Perez V.   Catafau A.M.   Corripio I.   Martin J.C.   Alvarez E.  

Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 27, Iss. 5, 2003-08 ,pp. : 767-770

Elsevier

Access to resources Recommend Favorite

Striatal dopamine D₂ receptors in medication-naive patients with major depressive disorder as assessed with [¹¹C]raclopride PET

By Hirvonen Jussi   Karlsson Hasse   Kajander Jaana   Markkula Juha   Rasi-Hakala Helena   Någren Kjell   Salminen Jouko   Hietala Jarmo  

Psychopharmacology, Vol. 197, Iss. 4, 2008-05 ,pp. : 581-590

Springer Publishing Company

Access to resources Recommend Favorite

Inhibition of striatal dopamine transporter activity by 17 -estradiol

By Disshon K.A.   Boja J.W.   Dluzen D.E.  

European Journal of Pharmacology, Vol. 345, Iss. 2, 1998-03 ,pp. : 207-211

Elsevier

Access to resources Recommend Favorite

The effect of vitamin E addition to acute neuroleptic treatment on the emergence of extrapyramidal side effects in schizophrenic patients: An open label study

By Dorfman-Etrog P.   Hermesh H.   Prilipko L.   Weizman A.   Munitz H.  

European Neuropsychopharmacology, Vol. 9, Iss. 6, 1999-12 ,pp. : 475-477

Elsevier

Access to resources Recommend Favorite